{
  "parties": [
    "SutroVax, Inc., a Delaware corporation having principal offices at 353 Hatch Dr., Foster City, CA 94404 (\"SutroVax\")",
    "Sutro Biopharma"
  ],
  "effective_date": null,
  "governing_law": null,
  "payment_terms": null,
  "termination_clause": {
    "text": "termination or cancellation fees charged by the Alternative Supplier; and\n\n(viii) include a mechanism for Sutro to cooperate with SutroVax and keep SutroVax reasonably informed with respect to Sutro's negotiation of an agreement with a potential Alternate Supplier for a Process Transfer and/or establishment of Capacity, including with respect to pricing for Extract from the Alternate Supplier to Sutro and any commitments to purchase quantities of Extract from the Alternate Supplier that SutroVax would be obligated to assume (e.g., in connection with establishing Capacity), if any, and require Sutro to obtain SutroVax' approval (not to be withheld unreasonably) of the terms of such agreement prior to entering into such agreement to the extent that the terms apply to SutroVax (it being understood that",
    "start": 29496,
    "end": 30307
  },
  "_doc_id": "VAXCYTE,INC_05_22_2020-EX-10.19-SUPPLY AGREEMENT.txt",
  "_char_count": 99696,
  "payment_net_days": null,
  "_issues": [
    {
      "field": "effective_date",
      "type": "MISSING",
      "detail": "Required field 'effective_date' is missing"
    },
    {
      "field": "governing_law",
      "type": "MISSING",
      "detail": "Required field 'governing_law' is missing"
    },
    {
      "field": "payment_terms",
      "type": "MISSING",
      "detail": "Required field 'payment_terms' is missing"
    }
  ]
}